Study of EPI-003 for chronic hepatitis B patients on antiviral therapy
Part of Digestive system, Infections clinical trials.
This trial tests a new medicine called EPI-003 for people with chronic hepatitis B who are already taking antiviral pills (like entecavir or tenofovir). The goal is to see if adding EPI-003 can further lower the virus and help the immune system. You must continue your current antiviral during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had chronic hepatitis B for at least 6 months and are positive for HBsAg.
- You have been taking a stable dose of an antiviral (entecavir or tenofovir) for at least 6 months and plan to stay on it.
- Your HBV DNA is undetectable (below the local lab's lower limit) for at least 6 months.
- Your liver enzymes (ALT and AST) are within 2 times the normal upper limit.
- You do not have significant liver scarring (cirrhosis) or other liver diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine, EPI-003, for people with chronic hepatitis B who are already on a stable antiviral treatment. It may help control the virus better or even achieve a functional cure.
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.